Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The challenge of HIV-1 genetic diversity: discordant CD4+ T-Cell count and viral load in an untreated patient infected with a subtype F strain.

Literature DB >> 19935211

The challenge of HIV-1 genetic diversity: discordant CD4+ T-Cell count and viral load in an untreated patient infected with a subtype F strain.

Hector Bolivar, Rebeca Geffin, Gabriel Manzi, Margaret A Fischl, Vera Holzmayer, Wai-Bing Mak, Klara Abravaya, John Hackett.

Abstract

Entities: Chemical

Mesh：

Substances：
RNA, Viral

Year: 2009 PMID： 19935211 PMCID： PMC9295325 DOI： 10.1097/QAI.0b013e3181b72539

Source DB: PubMed Journal: J Acquir Immune Defic Syndr ISSN： 1525-4135 Impact factor: 3.771

× No keyword cloud information.

9 in total

1. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor Monitor test, version 1.5: a case of unexpected vertical transmission.

Authors: Sibyl Geelen; Joep Lange; Jan Borleffs; Tom Wolfs; Annemarie Weersink; Rob Schuurman
Journal: AIDS Date: 2003-03-28 Impact factor: 4.177

2. Genetic characterization of diverse HIV-1 strains in an immigrant population living in New York City.

Authors: Hsi-Hsun Lin; Brian K Gaschen; Mary Collie; Mona El-Fishaway; Zhiwei Chen; Bette T Korber; Sally T Beatrice; Linqi Zhang
Journal: J Acquir Immune Defic Syndr Date: 2006-04-01 Impact factor: 3.731

3. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes.

Authors: Marie Gueudin; Jean Christophe Plantier; Véronique Lemée; Marie Paule Schmitt; Loic Chartier; Thomas Bourlet; Annick Ruffault; Florence Damond; Muriel Vray; François Simon
Journal: J Acquir Immune Defic Syndr Date: 2007-04-15 Impact factor: 3.731

4. The first B/G intersubtype recombinant form of human immunodeficiency virus type 1 (HIV-1) identified in Germany was undetected or underquantitated by some commercial viral load assays.

Authors: Inge von Truchsess; Barbara Harris; Hermann M Schätzl; John Hackett
Journal: J Med Virol Date: 2006-03 Impact factor: 2.327

5. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.

Authors: Priscilla Swanson; Carmen de Mendoza; Yagnya Joshi; Alan Golden; Richard L Hodinka; Vincent Soriano; Sushil G Devare; John Hackett
Journal: J Clin Microbiol Date: 2005-08 Impact factor: 5.948

6. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

Authors: Joris Hemelaar; Eleanor Gouws; Peter D Ghys; Saladin Osmanov
Journal: AIDS Date: 2006-10-24 Impact factor: 4.177

7. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.

Authors: F Damond; B Roquebert; A Bénard; G Collin; M Miceli; P Yéni; F Brun-Vezinet; D Descamps
Journal: J Clin Microbiol Date: 2007-08-22 Impact factor: 5.948

8. First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.

Authors: Michael Schmidt; Klaus Korn; C Micha Nübling; Michael Chudy; Julia Kress; Heinz A Horst; Geert Geusendam; Holger Hennig; Walid Sireis; Holger F Rabenau; Hans Wilhelm Doerr; Annemarie Berger; Michael Kai Hourfar; Knut Gubbe; Andreas Karl; Helmut Fickenscher; B Karsten Tischer; Reiner Babiel; Erhard Seifried; Lutz Gürtler
Journal: Transfusion Date: 2009-05-11 Impact factor: 3.157

9. HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversity.

Authors: Sylvia Lopes Maia Teixeira; Francisco Inácio Bastos; Paulo Roberto Telles; Mariana A Hacker; Luis F Brigido; Carmem Aparecida de F Oliveira; Vera Bongertz; Mariza Gonçalves Morgado
Journal: J Clin Virol Date: 2004-11 Impact factor: 3.168